These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2025546

  • 1. Do glomerular hemodynamic adaptations influence the progression of human renal disease?
    Woolf AS, Fine LG.
    Pediatr Nephrol; 1991 Jan; 5(1):88-93. PubMed ID: 2025546
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA, Abraham PA, Keane WF.
    Drugs; 1990 Jan; 39 Suppl 2():23-32. PubMed ID: 2188823
    [Abstract] [Full Text] [Related]

  • 3. The role of dietary protein in progressive renal disease.
    Brouhard BH.
    Am J Dis Child; 1986 Jul; 140(7):630-7. PubMed ID: 3521257
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.
    Opsahl JA, Abraham PA, Keane WF.
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):221-8. PubMed ID: 2285614
    [Abstract] [Full Text] [Related]

  • 5. Glomerular hypertension: cause and consequence of renal injury.
    Neuringer JR, Brenner BM.
    J Hypertens Suppl; 1992 Dec; 10(7):S91-7. PubMed ID: 1291662
    [Abstract] [Full Text] [Related]

  • 6. Diabetic nephropathy. The basis for dietary and converting enzyme inhibitor therapy.
    Narins RG, Kirshna GG.
    Am J Hypertens; 1988 Apr; 1(2):215-20. PubMed ID: 3041997
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases.
    Mimran A, Ribstein J.
    Am J Hypertens; 1994 Sep; 7(9 Pt 2):73S-81S. PubMed ID: 7818839
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic and biological correlates of glomerular hyperfiltration in sickle cell patients before and under renin-angiotensin system blocker.
    Haymann JP, Hammoudi N, Livrozet M, Santin A, Mattioni S, Letavernier E, Frochot V, Jacques CS, Steichen O, Grateau G, Chaignon M, Lionnet F.
    Sci Rep; 2021 Jun 03; 11(1):11682. PubMed ID: 34083624
    [Abstract] [Full Text] [Related]

  • 9. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic theory of progressive renal disease: a 10-year update in brief review.
    Neuringer JR, Brenner BM.
    Am J Kidney Dis; 1993 Jul 28; 22(1):98-104. PubMed ID: 8322801
    [Abstract] [Full Text] [Related]

  • 11. Preservation of renal reserve in chronic renal disease.
    Krishna GG, Kapoor SC.
    Am J Kidney Dis; 1991 Jan 28; 17(1):18-24. PubMed ID: 1986565
    [Abstract] [Full Text] [Related]

  • 12. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.
    Presse Med; 2002 Nov 09; 31(36):1714-20. PubMed ID: 12467154
    [Abstract] [Full Text] [Related]

  • 13. Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats.
    Anderson S, Rennke HG, Zatz R.
    Am J Physiol; 1994 Jul 09; 267(1 Pt 2):F35-43. PubMed ID: 8048562
    [Abstract] [Full Text] [Related]

  • 14. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M, Fazio M, Campanacci L, Carretta R.
    J Hypertens; 1999 Dec 09; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease.
    Anderson S, Brenner BM.
    Am J Hypertens; 1988 Oct 09; 1(4 Pt 2):380S-383S. PubMed ID: 3056448
    [Abstract] [Full Text] [Related]

  • 16. Glomerular hyperfiltration: definitions, mechanisms and clinical implications.
    Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW.
    Nat Rev Nephrol; 2012 Feb 21; 8(5):293-300. PubMed ID: 22349487
    [Abstract] [Full Text] [Related]

  • 17. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F, Verrotti A, Basciani F, di Ricco L, Sabatino G, Morgese G.
    J Pediatr Endocrinol Metab; 1998 Apr 21; 11 Suppl 2():365-9. PubMed ID: 9642666
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP, Raij L.
    Kidney Int Suppl; 1990 Nov 21; 30():S118-22. PubMed ID: 2259070
    [Abstract] [Full Text] [Related]

  • 19. Effect of diet, age and sex on the renal response to immune injury in the rat.
    Yared A, Miyazawa H, Purkerson ML, Klahr S, Salant DJ, Ichikawa I.
    Kidney Int; 1988 Feb 21; 33(2):561-70. PubMed ID: 3361756
    [Abstract] [Full Text] [Related]

  • 20. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus.
    Hollenberg NK, Price DA, Fisher ND, Lansang MC, Perkins B, Gordon MS, Williams GH, Laffel LM.
    Kidney Int; 2003 Jan 21; 63(1):172-8. PubMed ID: 12472780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.